FDA grants Priority Review to Amitiza sNDA

Sucampo Pharmaceuticals Inc. (NASDAQ:SCMP) and Takeda Pharmaceutical Co. Ltd. (Tokyo:4502) announced late Tuesday that FDA granted Priority Review to an sNDA for Amitiza lubiprostone to treat opioid-i...